Aimed Alliance Submits Public Comment on ICER’s Flawed Drug Pricing Assessment 0 By Aimed Alliance on February 13, 2019 Aimed Activity, Comments & Sign-on Letters, Drug Pricing, Drug Pricing: Policy Activity, Resources, Value, Value: Policy Activity Last Updated on October 24, 2019 by Advocacy Value Share. Twitter Facebook Pinterest LinkedIn Tumblr Email
February 7, 2025 Survey Finds 30% of Independent Pharmacies Will Not Stock Certain IRA-Negotiated Drugs
February 7, 2025 Aimed Alliance Advocates for Clarifications to WA Obesity Treatment Access Legislation
